X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Dr. Reddys with AANJANEYA LIFECARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs DR. DATSONS LABS - Comparison Results

DR. REDDYS LAB    Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB DR. DATSONS LABS DR. REDDYS LAB/
DR. DATSONS LABS
 
P/E (TTM) x 40.5 -10.9 - View Chart
P/BV x 3.1 0.2 1,910.9% View Chart
Dividend Yield % 0.9 0.0 -  

Financials

 DR. REDDYS LAB   DR. DATSONS LABS
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-17
DR. DATSONS LABS
Mar-14
DR. REDDYS LAB/
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs3,397126 2,704.4%   
Low Rs2,56031 8,284.8%   
Sales per share (Unadj.) Rs856.5133.0 644.0%  
Earnings per share (Unadj.) Rs78.00.2 51,420.8%  
Cash flow per share (Unadj.) Rs139.96.6 2,117.2%  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %0.70-  
Book value per share (Unadj.) Rs739.8128.8 574.5%  
Shares outstanding (eoy) m165.7431.66 523.5%   
Bonus/Rights/Conversions BBFCCB-  
Price / Sales ratio x3.50.6 591.0%   
Avg P/E ratio x38.2516.1 7.4%  
P/CF ratio (eoy) x21.311.8 179.8%  
Price / Book Value ratio x4.00.6 662.6%  
Dividend payout %25.70-   
Avg Mkt Cap Rs m493,6322,477 19,925.4%   
No. of employees `00022.7NA-   
Total wages/salary Rs m31,06856 55,478.6%   
Avg. sales/employee Rs Th6,259.0NM-  
Avg. wages/employee Rs Th1,369.8NM-  
Avg. net profit/employee Rs Th569.7NM-  
INCOME DATA
Net Sales Rs m141,9614,211 3,371.6%  
Other income Rs m1,71579 2,179.2%   
Total revenues Rs m143,6764,289 3,349.7%   
Gross profit Rs m24,722569 4,347.9%  
Depreciation Rs m10,266204 5,022.5%   
Interest Rs m634430 147.4%   
Profit before tax Rs m15,53713 122,338.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m349-2 -19,388.9%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,9656 48,606.6%   
Profit after tax Rs m12,9215 269,187.5%  
Gross profit margin %17.413.5 129.0%  
Effective tax rate %19.148.0 39.7%   
Net profit margin %9.10.1 7,984.0%  
BALANCE SHEET DATA
Current assets Rs m96,8376,852 1,413.3%   
Current liabilities Rs m84,1996,711 1,254.7%   
Net working cap to sales %8.93.3 265.8%  
Current ratio x1.21.0 112.6%  
Inventory Days Days73161 45.6%  
Debtors Days Days98318 30.7%  
Net fixed assets Rs m102,5523,673 2,792.1%   
Share capital Rs m829317 261.8%   
"Free" reserves Rs m121,7923,761 3,238.3%   
Net worth Rs m122,6214,078 3,007.3%   
Long term debt Rs m5,4491,671 326.1%   
Total assets Rs m218,16512,633 1,727.0%  
Interest coverage x25.51.0 2,477.5%   
Debt to equity ratio x00.4 10.8%  
Sales to assets ratio x0.70.3 195.2%   
Return on assets %6.23.4 180.4%  
Return on equity %10.50.1 8,951.3%  
Return on capital %12.97.7 168.1%  
Exports to sales %54.622.9 238.5%   
Imports to sales %9.414.3 65.4%   
Exports (fob) Rs m77,520964 8,041.5%   
Imports (cif) Rs m13,274602 2,205.3%   
Fx inflow Rs m81,670964 8,472.0%   
Fx outflow Rs m26,355607 4,341.1%   
Net fx Rs m55,315357 15,498.7%   
CASH FLOW
From Operations Rs m21,4441,345 1,594.6%  
From Investments Rs m-18,404-2,256 815.9%  
From Financial Activity Rs m-3,692-1,200 307.7%  
Net Cashflow Rs m-1,144-2,111 54.2%  

Share Holding

Indian Promoters % 25.5 4.5 562.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 5.4 0.0 -  
FIIs % 35.3 1.4 2,614.8%  
ADR/GDR % 18.5 0.0 -  
Free float % 15.3 94.1 16.3%  
Shareholders   75,885 20,807 364.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   GLENMARK PHARMA  FRESENIUS KABI ONCO.  FDC LTD.  ASTRAZENECA PHARMA  DISHMAN PHARMA  

Compare DR. REDDYS LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 219 Points Lower; Energy and Auto Stocks Witness Selling(Closing)

After witnessing volatile trades during the day, Indian share markets ended their session on a negative note. Losses were largely seen in the oil & gas sector, auto sector.

Related Views on News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

This Behaviour is Injurious to Wealth Building(Sector Info)

Jun 13, 2018

Blindly following the herd can be the biggest wealth destroyer.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Jun 25, 2018 03:35 PM

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB 5-YR ANALYSIS

COMPARE DR. REDDYS LAB WITH

MARKET STATS